Zacharias Nikolaos, Wang Grace J, Sedrakyan Art, Columbo Jesse A, Boyle Jonathan R, Goodney Philip P
Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
Division of Vascular Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA.
Ann Vasc Surg. 2019 Aug;59:293-299. doi: 10.1016/j.avsg.2019.02.010. Epub 2019 Apr 19.
The use of fenestrated endovascular devices for repair of complex aortic aneurysms has increased to nearly 5,000 implantations annually among Medicare patients in the United States in recent years. Given that nearly all aspects of treatment for minimally invasive aortic intervention rely on medical devices to better care for patients with vascular disease, clearly understanding how new and innovative technology evolves over the life cycle of a medical device is an essential skill set for cardiovascular physicians. Despite the need for this understanding, there is no standard framework upon which cardiovascular physicians, regulators, and patients can rely on to better understand the evolution of evidence from product inception through adoption and long-term effectiveness evaluation. As the aforementioned devices are increasingly and broadly used, the need for a formal framework for regulation and device approval has emerged. The goal of this review is to describe the Idea, Development, Exploration, Assessment, Long-term Study Framework for Devices (IDEAL-D). This framework is a model developed recently by an international panel of experts dedicated to better understanding the data steps necessary to bring a device from idea to routine practice and further to marketing, approval, and monitoring. In this review, we use the example of fenestrated endovascular aortic devices to illustrate the IDEAL-D framework, how it can help cardiovascular physicians improve their understanding of new technology, and the evidence which surrounds it from inception to long-term use.
近年来,在美国医疗保险患者中,用于修复复杂主动脉瘤的开窗式血管内装置的使用量已增至每年近5000例植入手术。鉴于微创主动脉介入治疗的几乎所有方面都依赖医疗设备来更好地治疗血管疾病患者,清楚了解新技术和创新技术在医疗设备生命周期中的发展过程,是心血管内科医生必备的技能。尽管需要这种理解,但目前尚无一个标准框架可供心血管内科医生、监管机构和患者用以更好地理解从产品构思到采用以及长期有效性评估的证据演变过程。随着上述装置的使用日益广泛,对正式的监管和设备批准框架的需求应运而生。本综述的目的是描述器械的构思、开发、探索、评估、长期研究框架(IDEAL-D)。该框架是一个由国际专家小组最近开发的模型,旨在更好地理解将一种设备从构思转化为常规实践,进而推向市场、获得批准和进行监测所需的数据步骤。在本综述中,我们以开窗式血管内主动脉装置为例来说明IDEAL-D框架,它如何帮助心血管内科医生更好地理解新技术,以及从构思到长期使用围绕该技术的证据。